Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28489775 | 0.98 | KDM4E (0.49) | KDM4EALDH1A1TP53TSHRHPGD | |
| SCHEMBL2513525 | 0.90 | EGFR (0.47) | KDM4EALDH1A1TP53TSHRNPC1 | |
| SCHEMBL17303478 | 0.87 | LMNA (0.37) | KDM4EALDH1A1HPGDKMT2ANPC1 | |
| SCHEMBL2516837 | 0.86 | DHODH (0.46) | KDM4EALDH1A1MKNK1MKNK2 | |
| SCHEMBL28781255 | 0.85 | MKNK1 (0.49) | MKNK1MKNK2 | |
| SCHEMBL5485083 | 0.84 | NPC1 (0.44) | KDM4EALDH1A1HPGDKMT2ANPC1 | |
| SCHEMBL7432657 | 0.84 | XDH (0.51) | TP53HPGDKMT2ANPC1RAB9A | |
| SCHEMBL751010 | 0.84 | MKNK1 (0.42) | ALDH1A1KMT2AMAP2K4MKNK1MKNK2 | |
| SCHEMBL9067093 | 0.84 | KDM4E (0.34) | KDM4EALDH1A1HPGDKMT2A | |
| SCHEMBL24690305 | 0.83 | RXRA (0.44) | KDM4EALDH1A1BCL2L1BADCSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| CN-119926404-A | Carbonized Co-MOF powder, supported membrane, sandwich structure limited-domain catalytic membrane and preparation method | 清华大学深圳国际研究生院 | 2025-05-06 | — | — | CN | claimed |
| CN-117757094-A | Preparation method and application of EuTb mixed coordination fluorescent rare earth metal-organic framework material | 东华理工大学 | 2024-03-26 | — | — | CN | claimed |
| US-20240011009-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2024-01-11 | — | — | US | claimed |
| CN-117106189-A | Metal organic framework artificial hydrolase and preparation method and application thereof | 华南理工大学 | 2023-11-24 | — | — | CN | claimed |
| US-20230220589-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2023-07-13 | — | — | US | claimed |
| EP-4127157-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| CN-114805233-A | Phenyl tetrazole type XOR inhibitor and preparation method and application thereof | 华南理工大学 | 2022-07-29 | — | — | CN | claimed |
| WO-2022072560-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2022-04-07 | — | — | WO | claimed |
| CN-111234243-B | Metal organic framework material, preparation method thereof and immunosensor | 郑州轻工业大学 | 2021-10-01 | — | — | CN | claimed |
| US-20140206825-A1 | SUPPORTED ALKOXYLATED ORGANOTIN REACTANT, PREPARATION AND USE FOR HETEROGENEOUS-PHASE SYNTHESIS OF TETRAZOLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-07-24 | — | — | US | claimed |
| US-20100292334-A1 | N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | NEUROSEARCH A/S (DK) | 2010-11-18 | — | — | US | claimed |
| EP-2222308-A1 | N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | NeuroSearch AS (DK) | 2010-09-01 | — | — | EP | claimed |
| WO-2009065850-A1 | N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | NEUROSEARCH A/S (DK) | 2009-05-28 | — | — | WO | claimed |
| US-6576414-B1 | PKsp of said first organic silver salt is at least 0.5 lower than the pKsp of said second silver salt; high speed, storage stable | EASTMAN KODAK COMPANY | 2003-06-10 | — | — | US | claimed |
| US-6548236-B1 | The dye-providing couplers in the multilayers being different in hue, forming at least three dye images of different visible or non-visible colors | EASTMAN KODAK COMPANY | 2003-04-15 | — | — | US | claimed |
| EP-1299769-A1 | MIXTURES OF ORGANIC SILVER SALTS IN COLOR PHOTOTHERMOGRAPHIC SYSTEMS | EASTMAN KODAK COMPANY (US) | 2003-04-09 | — | — | EP | claimed |
| US-6426181-B2 | THE SECOND SILVER SALT IS A THERMAL FOG INHIBITOR THAT PREVENTS DESORPTION OF SENSITIZING DYES FROM THE IMAGING SILVER HALIDE GRAINS AND IS PREFERABLY A MERCAPTO-HETEROCYCLIC COMPOUND | EASTMAN KODAK COMPANY | 2002-07-30 | — | — | US | claimed |
| US-20020015928-A1 | Mixtures of organic silver salts in color photothermographic systems | IRVING LYN M (US) | 2002-02-07 | — | — | US | claimed |
| WO-2001096949-A1 | MIXTURES OF ORGANIC SILVER SALTS IN COLOR PHOTOTHERMOGRAPHIC SYSTEMS | EASTMAN KODAK COMPANY (US) | 2001-12-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292334-A1 | N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | CHRNA3, CHRNA6, CHRNA2 | KDM4E 2391/4885ALDH1A1 614/4885TP53 4823/4885 |
| US-20140206825-A1 | SUPPORTED ALKOXYLATED ORGANOTIN REACTANT, PREPARATION AND USE FOR HETEROGENEOUS-PHASE SYNTHESIS OF TETRAZOLES | ALK, TST, TEKT1 | KDM4E 3246/4885ALDH1A1 861/4885TP53 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.